Aktis Oncology: Mpm funds buy shares worth $20m

On January 12, 2026, MPM Funds purchased 1,112,777 shares of Aktis Oncology, Inc. (NASDAQ:AKTS) at a price of $18.00 per share, for a total transaction value of $20,029,986. AKTS shares currently ...

Aktis Oncology (AKTS) sees $20 million purchase by 10% owner

On January 12, 2026, Aktis Oncology, Inc. (AKTS) saw a purchase of 1,112,777 shares of common stock at $18 per share, for a total value of $20,029,986. The transaction was reported in a Form 4 filing ...
Seeking Alpha

Virtus Diversified Income & Convertible Fund Announces Redemption of Class A Mandatory Redeemable Preferred Shares

HARTFORD, Conn.--(BUSINESS WIRE)-- The Virtus Diversified Income & Convertible Fund (ACV) (NYSE: ACV) today announced the redemption of all 1,200,000 issued and outstanding Class A Mandatory ...
Hosted on MSN

SEBI Proposes Allowing Zero-Coupon Bonds At Reduced Face Value Of Rs 10,000

SEBI on Friday proposed a modification in rules by allowing issuance of zero-coupon debt securities and non-convertible redeemable preference shares at a reduced face value of Rs 10,000. The move came ...